RLYB earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -11.15. Updated 2026-07-23.
Rallybio (RLYB) Research Hub
Rallybio (RLYB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 16.65 USD (+0.06%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -11.15, market cap 0.09B. This hub links to the full technical, earnings and options research available for RLYB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 16.65 USD (+0.06%) |
| 52-week range | 15.61 USD – 17.35 USD |
| Trend regime | Range |
| 14-day RSI | 39.5 (Bearish) |
| Trailing P/E | -11.15 |
| Market cap | 0.09B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for RLYB
Covered Call on RLYB: how it works, illustrative setup around the real 16.65 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RLYB: how it works, illustrative setup around the real 16.65 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RLYB: how it works, illustrative setup around the real 16.65 USD price, max profit/loss, breakeven and when to use it. Educational.
RLYB technical analysis: range, last 16.65 USD, RSI 39.5, 52w range 15.61 USD–17.35 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is RLYB in?
Rallybio (RLYB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is RLYB in an uptrend or downtrend?
As of 2026-10-26, RLYB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RLYB's trailing P/E ratio?
RLYB's trailing P/E is -11.15, with a market cap of 0.09B. See the earnings research page for full valuation detail.
When does RLYB next report earnings?
RLYB is next scheduled to report earnings on 2026-08-06.